Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Redwood City › NPI 1235172057
Hospital

Sequoia Health Services

Sequoia Health Services was paid $1.96M by Medicaid between Feb 2018 and May 2023, across 53 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.

33Billing provider infoSEQUOIA HEALTH SERVICES
REDWOOD CITY, CA 94062
33aNPI1235172057assigned 06/13/2006
28Total paid$1.96M
24GClaims50,485
24DCodes billed53
24AFirst – last monthFeb 2018 – May 2023
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#254 of 410
Median peer was paid$6.90M
This provider vs. median0.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,913$66K
201912,265$419K
20208,657$326K
202110,158$361K
202212,461$569K
20235,031$217K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 23% 5,141 4,892 $454K
99282 Emergency department visit for the evaluation and management, low to moderate severity 15% 3,963 3,662 $285K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 3,172 3,000 $284K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 7.7% 2,092 1,889 $150K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 4.9% 570 567 $96K
80053 Comprehensive metabolic panel 3.3% 3,520 3,257 $64K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.2% 679 666 $63K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3.2% 1,827 1,713 $62K
96375 Therapeutic injection; each additional sequential IV push 3.2% 1,363 1,210 $62K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.6% 3,871 3,514 $51K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 2.0% 107 107 $38K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1.9% 614 604 $37K
41 more codes
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.6% 926 $31K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.2% 108 $24K
97139 1.1% 1,211 $21K
0450 Emergency room services 1.1% 543 $21K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 230 $18K
84484 <1% 998 $17K
71045 Radiologic examination, chest; single view <1% 1,100 $14K
96361 Intravenous infusion, hydration; each additional hour <1% 543 $14K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 142 $14K
70450 Computed tomography, head or brain; without contrast material <1% 62 $14K
83690 <1% 1,156 $13K
99070 <1% 6,364 $13K
J3490 Unclassified drugs <1% 1,478 $12K
81001 <1% 1,575 $9K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,440 $8K
87086 Culture, bacterial; quantitative colony count, urine <1% 714 $7K
J7030 Infusion, normal saline solution , 1000 cc <1% 861 $7K
87581 <1% 108 $7K
87486 <1% 109 $7K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,233 $7K
71046 Radiologic examination, chest; 2 views <1% 269 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 315 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 166 $5K
81025 <1% 484 $4K
82550 <1% 323 $3K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 45 $3K
87631 <1% 51 $3K
80048 Basic metabolic panel (calcium, ionized) <1% 130 $2K
81003 <1% 414 $2K
87430 <1% 82 $1K
82553 <1% 57 $999.19
87081 <1% 70 $728.82
J1170 Injection, hydromorphone, up to 4 mg <1% 97 $721.70
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 74 $475.19
84443 Thyroid stimulating hormone (TSH) <1% 13 $397.20
80061 Lipid panel <1% 12 $215.38
87186 <1% 12 $200.28
83605 <1% 13 $186.66
83036 Hemoglobin; glycosylated (A1C) <1% 12 $180.30
J2270 Injection, morphine sulfate, up to 10 mg <1% 13 $120.20
87077 <1% 13 $90.60

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBARTON, GRATIA (VP CFO)
Parent organizationSEQUOIA HEALTH SERVICES